Product identity records
The records below identify substances, strengths and forms or presentations for documentary enquiries with GALVANTA COMPANY LIMITED.
The company holds no pharmaceutical manufacturing licence, GMP certificate, product registration or marketing authorisation. No Cambodian product registration or marketing authorisation is held for any presentation listed here. The company states that registration of the presentations listed on this website in Cambodia is in process.
Reading a record
A record does not establish approval, lawful advertising, manufacture, supply or suitability for a patient. Authorisation for the company and the presentation shown here requires separate evidence from an authorisation held by another organisation or in another country.
Where a record lists more than one strength or presentation, each combination requires its own evidence. Individual pages contain the supplied pack information.
Search product records
Search by substance name, strength or presentation.
No product records match your search. Clear the search field to show all records.
Records
| Record | Strength | Form or presentation |
|---|---|---|
| Anastrozole | 1 mg per tablet | Tablet |
| Boldenone Undecylenate | 250 mg/mL | Oil injection |
| Cabergoline | 0.25 mg per tablet | Tablet |
| Chlorodehydromethyltestosterone | 10 mg per tablet | Tablet |
| Clenbuterol | 40 mcg per tablet | Tablet |
| Clomiphene Citrate | 50 mg per tablet | Tablet |
| Dapoxetine | 60 mg per tablet | Tablet |
| Dihydroboldenone Cypionate | 50 mg/mL | Oil injection |
| Drostanolone Enanthate | 200 mg/mL | Oil injection |
| Drostanolone Propionate | 100 mg/mL | Oil injection |
| Enclomiphene Citrate | 25 mg per tablet | Tablet |
| Estradiol | 0.5 mg / 1 mg / 2 mg tablets | Tablet |
| Estradiol Valerate | 20 mg/mL / 40 mg/mL | Oil injection |
| Exemestane | 25 mg per tablet | Tablet |
| Fluoxymesterone | 5 mg per tablet | Tablet |
| Human chorionic gonadotropin (HCG) | 6500 IU per pen | Dual-cartridge / pen presentation |
| Letrozole | 2.5 mg per tablet | Tablet |
| Levothyroxine Sodium | 25–200 mcg tablets | Tablet |
| Liothyronine | 25 mcg per tablet | Tablet |
| Mesterolone | 25 mg per tablet | Tablet |
| Methandienone | 10 mg per tablet | Tablet |
| Methenolone Acetate | 25 mg per tablet | Tablet |
| Methenolone Enanthate | 100 mg/mL | Oil injection |
| Micronised Progesterone | 100 mg / 200 mg capsules | Soft capsule |
| Modafinil | 200 mg per tablet | Tablet |
| Nandrolone Decanoate | 250 mg/mL | Oil injection |
| Nandrolone Phenylpropionate | 100 mg/mL | Oil injection |
| Orlistat | 120 mg per capsule | Capsule |
| Oxandrolone | 10 mg per tablet | Tablet |
| Oxandrolone | 25 mg per tablet | Tablet |
| Oxymetholone | 25 mg per tablet | Tablet |
| Bremelanotide / PT-141 | 30 mg per pen | Dual-cartridge / pen presentation |
| Sildenafil | 25 mg per tablet | Tablet |
| Silver Sulfadiazine | 1% cream | Topical cream |
| Somatropin | 36 IU per pen | Dual-cartridge / pen presentation |
| Somatropin | 72 IU per pen | Dual-cartridge / pen presentation |
| Stanozolol | 10 mg per tablet | Tablet |
| Tadalafil | 10 mg per tablet | Tablet |
| Tamoxifen Citrate | 10 mg / 20 mg tablets | Tablet |
| Tenofovir Disoproxil Fumarate | 300 mg per tablet | Film-coated tablet |
| Testosterone Base | 100 mg/mL | Suspension injection |
| Testosterone Blend | 250 mg/mL | Oil injection |
| Testosterone Cypionate | 250 mg/mL | Oil injection |
| Testosterone Enanthate | 250 mg/mL | Oil injection |
| Testosterone Propionate | 100 mg/mL | Oil injection |
| Testosterone | 1% gel; 1.62% metered-dose presentation | Topical gel |
| Testosterone Undecanoate | 250 mg/mL injection; 40 mg oral presentation | Oil injection; capsule |
| Trenbolone Acetate | 100 mg/mL | Oil injection |
| Trenbolone Aqueous Suspension | 50 mg/mL | Suspension injection |
| Trenbolone Enanthate | 200 mg/mL | Oil injection |
| Trenbolone Hexahydrobenzylcarbonate | 76.5 mg/mL | Oil injection |
| Trestolone Acetate | 50 mg/mL vial; 25 mg/mL ampoule | Oil injection |
| Trestolone Enanthate | 50 mg/mL vial; 25 mg/mL ampoule | Oil injection |
| Valacyclovir Hydrochloride | 500 mg / 1 g tablets | Film-coated tablet |
| Vardenafil | 20 mg per tablet | Tablet |
| Zopiclone | 7.5 mg per tablet | Tablet |
Documentary enquiries
Email [email protected], identifying the exact record, jurisdiction, organisation and document requested. The existence and releasability of a requested document require separate assessment.
The Product information policy explains the publication boundaries. The Regulatory page states the company’s status.
For a suspected adverse event or product defect, use Adverse-event reporting or Product-quality concerns.